Comparison of intravitreal bevacizumab and triamcinolone acetonide for diabetic macular edema Hisato Ohno 1 , Ryo Moriyama 1 , Michitaka Sugahara 1 , Masato Wakakura 1 1Inouye Eye Hosp pp.307-309
Published Date 2009/3/15
DOI https://doi.org/10.11477/mf.1410102627
  • Abstract
  • Look Inside
  • Reference

Abstract. Purpose:To compare the effect of intravitreally injected bevacizumab and triamcinolone acetonide for diabetic macular edema. Cases and Method:This study was made on 24 eyes of 20 patients with diabetic macular edema. The series comprised 10 males and 10 females. The age averaged 62 years. Fourteen eyes received intravitreal injection of bevacizumab and 10 eyes received triamcinolone. Cases were followed up for 24 weeks. Visual acuity was evaluated as logMAR. Foveal thickness was measured by optical coherence tomography. Results:Both groups showed improvements in visual acuity and foveal thickness. There was no difference between the two groups. There was no elevation of intraocular pressure throughout. Conclusion:Intravitreal injection of bevacizumab or triamcinolone was equally effective for diabetic macular edema up to 24 weeks.

Copyright © 2009, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院